×

Registration

Profile Information

Login Data

or login

First name is required!
Last name is required!
First name is not valid!
Last name is not valid!
This is not an email address!
Email address is required!
This email is already registered!
Password is required!
Enter a valid password!
Please enter 6 or more characters!
Please enter 16 or less characters!
Passwords are not same!
Terms and Conditions are required!
Email or Password is wrong!
 
The Clinical Trials Process
RESEARCHER
 
40 females

Glynis Ablon, M.D., FAAD, Ablon Skin Institute Research Center, University of California, Los Angeles, California, U.S.A.; and Steven Dayan, M.D., FACS, DeNova Research, Chicago, Illinois, U.S.A.

70 females

Thomas J. Stephens & Associates, Inc., Dallas Research Center, Carrollton, Texas, U.S.A.

40 females

Glynis Ablon, M.D., FAAD, Ablon Skin Institute Research Center, University of California, Los Angeles, California, U.S.A.; and Steven Dayan, M.D., FACS, DeNova Research, Chicago, Illinois, U.S.A.

 
RESULTS

(In progress) 6-month, multi-center, randomized, double-blind, placebo-controlled clinical trial.

Hypothesis: ingestion of oral Viviscal supplement will strengthen and promote terminal hairs in female subjects, ages 21-75, who have self-perceived thinning hair

Estimated publication date: summer 2015

6-month double-blind, placebo-controlled clinical trial demonstrated statistically significant results:

18.3% reduction in hair shedding vs. placebo 7.4% increase in hair thickness vs. placebo

Abstract presented: 7th World Congress for Hair Research (2013; Edinburgh, Scotland)

6-month double-blind, placebo-controlled clinical trial demonstrated statistically significant results:

125% increase in terminal hairs vs. placebo group Significant, self-perceived improvements in overall hair volume, thickness and scalp coverage Published: The Journal of Clinical and Aesthetic Dermatology (Nov. 2012